The therapeutic antibodies market also covers monoclonal cancer antibodies that are intended to detect, linking and/or neutralizing of antigens or immune mechanisms against malignant cells. They are naked antibodies, drug antibodies (ADCs), diaspora antibodies and antibodies which are used as immune control point inhibitors or in dual circuits. the goal. The stakeholders keep an eye o... https://www.metatechinsights.com/industry-insights/cancer-monoclonal-antibodies-market-2503